Gilde Healthcare Partners recruits new partners and opens new office in the US - Gilde Healthcare

Gilde Healthcare Partners recruits new partners and opens new office in the US

10 November 2011

Utrecht, the Netherlands | Cambridge, USA – Gilde Healthcare Partners a €450 million ($600 million) venture and growth capital group based in Utrecht, Netherlands has announced the opening of its office in Cambridge, MA. The firm’s US investment activity is managed by Geoff Pardo who recently joined Gilde as Partner. Geoff has spent the last eleven years in a mix of venture capital and operating roles at Cardinal Partners, Spray Venture Partners and most recently as CEO of Facet Solutions, a spinal implant company that was sold to Globus Medical.  
In addition, Janke Dittmer joined Gilde Healthcare, in The Netherlands, as Partner. Janke has been senior director new business development and venture general manager at Philips Healthcare’s corporate venturing unit. Prior to this he was a manager at McKinsey.

Earlier this week Gilde announced the first investment from Gilde Healthcare III in Inova Labs based in Austin, TX. Inova Labs has developed a novel, proprietary portable oxygen concentrator which allows for greater patient mobility for patients suffering from Chronic Obstructive Pulmonary Disease. The new round allows Inova to expand commercialization of its flagship product, LifeChO2ice.

About Gilde Healthcare Partners

Netherlands-based Gilde Healthcare Partners is a transatlantic venture and growth capital firm focused on private healthcare technology and service companies. It has over €450 million ($600 million) under management and is actively looking to lead new investments in therapeutics, diagnostics, medical devices and healthcare services. Gilde successfully builds healthcare businesses across Europe and US, investing up to €15 million ($20 million) in a single portfolio company. For a list of Gilde’s portfolio companies please visit the website at www.gildehealthcare.com.

Contact details

Gilde Healthcare Partners US Inc.
245 First Street, 18th floor
Cambridge, MA 02142
U.S.A.
Tel.: +1 617 395 9080

Gilde Healthcare Partners BV
Newtonlaan 91
3508 AB Utrecht
The Netherlands
Tel.: +31 30 219 2528

Gilde Healthcare portfolio company Nyxoah announces CE-mark approval to treat complete concentric collapse (CCC) patients

Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that DEKRA Notified Body has approved...
5 October 2021

Gilde Healthcare portfolio company Noema Pharma appoints Jeffrey Jonas as Independent Chairman of the Board of Directors

Noema Pharma, a Swiss-based clinical stage company targeting orphan central nervous system (CNS) diseases, today announces the appointment of Jeffrey Jonas MD as Chairman of the Board of Directors. Dr. Jonas is a neuropsychiatry expert...
4 October 2021

Gilde Healthcare company Acacia Pharma announces marketing authorization application for BARHEMSYS® in Europe

Acacia Pharma (EURONEXT: ACPH), a commercial stage biopharmaceutical company focused on developing and commercializing novel products to improve the care of patients undergoing serious medical treatments such as surgery, invasive procedures, or cancer chemotherapy, announces...
29 September 2021